A handheld camera for screening eye diseases in newborns
RetiVue EntireEye - A Handheld, High-Resolution, Non-Contact, One Image, Widefield Retinal Screening Camera for Premature and Healthy Newborn Babies
This study is working on a new, easy-to-use camera that takes clear pictures of the eyes of premature babies to help doctors quickly check for vision problems, making it simpler to get the care these little ones need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Retivue NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11068765 on NIH RePORTER |
What this research studies
This research focuses on developing a portable, high-resolution camera designed to screen for retinopathy of prematurity (ROP) in newborn babies. The camera captures detailed images of the retina in a single shot, making it easier and more efficient to diagnose potential vision problems. By utilizing advanced imaging technology and artificial intelligence, the device aims to provide high-quality diagnostic images that can be used for telemedicine applications, ensuring timely screening for all infants. This approach addresses the shortage of trained ophthalmologists and the limitations of current screening methods.
Who could benefit from this research
Good fit: Ideal candidates for this research are premature newborns, particularly those under 4 weeks old, who are at risk for retinopathy of prematurity.
Not a fit: Patients who are not newborns or those who do not have risk factors for retinopathy of prematurity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve early detection and treatment of eye diseases in premature infants, potentially preventing blindness.
How similar studies have performed: Previous research has shown success with telemedicine approaches in screening for eye diseases, indicating that this novel technology could also be effective.
Where this research is happening
Charlottesville, United States
- Retivue — Charlottesville, United States (Active)
Researchers
- Principal investigator: Yates, Paul a. — Retivue
- Study coordinator: Yates, Paul a.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.